IASO Biotherapeutics Secures $108 Million Series C Funding to Advance Global Development of Innovative Cell Therapies
PLEASANTON, Calif. & NANJING, China & SHANGHAI--(BUSINESS WIRE)--#BioPharmaceutical--IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company…